Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth.

TitleLive imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth.
Publication TypeJournal Article
Year of Publication2008
AuthorsGounaris E, Tung CH, Restaino C, Maehr R, Kohler R, Joyce JA, Ploegh HL, Plough HL, Barrett TA, Weissleder R, Khazaie K
JournalPLoS One
Volume3
Issue8
Paginatione2916
Date Published2008 Aug 13
ISSN1932-6203
KeywordsAdenomatous Polyposis Coli, Animals, Cathepsins, Cysteine, Disease Models, Animal, Flow Cytometry, Genes, APC, Genes, Suppressor, Inflammation, Intestinal Polyps, Macrophages, Mice, Mice, Inbred C57BL
Abstract

It has been estimated that up to 30% of detectable polyps in patients regress spontaneously. One major challenge in the evaluation of effective therapy of cancer is the readout for tumor regression and favorable biological response to therapy. Inducible near infra-red (NIR) fluorescent probes were utilized to visualize intestinal polyps of mice hemizygous for a novel truncation of the Adenomatous Polyposis coli (APC) gene. Laser Scanning Confocal Microscopy in live mice allowed visualization of cathepsin activity in richly vascularized benign dysplastic lesions. Using biotinylated suicide inhibitors we quantified increased activities of the Cathepsin B & Z in the polyps. More than (3/4) of the probe signal was localized in CD11b(+)Gr1(+) myeloid derived suppressor cells (MDSC) and CD11b(+)F4/80(+) macrophages infiltrating the lesions. Polyposis was attenuated through genetic ablation of cathepsin B, and suppressed by neutralization of TNFalpha in mice. In both cases, diminished probe signal was accounted for by loss of MDSC. Thus, in vivo NIR imaging of focal cathepsin activity reveals inflammatory reactions etiologically linked with cancer progression and is a suitable approach for monitoring response to therapy.

DOI10.1371/journal.pone.0002916
Alternate JournalPLoS One
PubMed ID18698347
PubMed Central IDPMC2488397
Grant ListR01 CA104547 / CA / NCI NIH HHS / United States
R01 DK054778 / DK / NIDDK NIH HHS / United States
R01 CA125162 / CA / NCI NIH HHS / United States
R01 AI061701-04 / AI / NIAID NIH HHS / United States
R01 DK054778-10 / DK / NIDDK NIH HHS / United States
R01 DK054778-02 / DK / NIDDK NIH HHS / United States
R01 DK054778-08 / DK / NIDDK NIH HHS / United States
R01 DK054778-01 / DK / NIDDK NIH HHS / United States
R01 AI061701 / AI / NIAID NIH HHS / United States
R01 DK054778-05 / DK / NIDDK NIH HHS / United States
R01 DK054778-09 / DK / NIDDK NIH HHS / United States
R01 AI061701-05 / AI / NIAID NIH HHS / United States
R01 AI061701-02 / AI / NIAID NIH HHS / United States
R01-CA125162 / CA / NCI NIH HHS / United States
R01 CA104547-03 / CA / NCI NIH HHS / United States
R01 DK054778-07 / DK / NIDDK NIH HHS / United States
R01 AI061701-03 / AI / NIAID NIH HHS / United States
R01 DK054778-06 / DK / NIDDK NIH HHS / United States
R01 DK054778-03 / DK / NIDDK NIH HHS / United States
R01 DK054778-04 / DK / NIDDK NIH HHS / United States
R01 AI061701-01A1 / AI / NIAID NIH HHS / United States
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065